X Gao1, A Cassidy, M A Schwarzschild, E B Rimm, A Ascherio. 1. Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School,Boston, MA, USA. xiang.gao@channing.harvard.edu
Abstract
OBJECTIVE: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD). METHODS: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire. RESULTS: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40%lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both). CONCLUSIONS: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.
OBJECTIVE: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD). METHODS: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire. RESULTS: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40%lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both). CONCLUSIONS: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.
Authors: John W Erdman; Douglas Balentine; Lenore Arab; Gary Beecher; Johanna T Dwyer; John Folts; James Harnly; Peter Hollman; Carl L Keen; G Mazza; Mark Messina; Augustin Scalbert; Joseph Vita; Gary Williamson; Jerrilynn Burrowes Journal: J Nutr Date: 2007-03 Impact factor: 4.798
Authors: Xiang Gao; Honglei Chen; Teresa T Fung; Giancarlo Logroscino; Michael A Schwarzschild; Frank B Hu; Alberto Ascherio Journal: Am J Clin Nutr Date: 2007-11 Impact factor: 7.045
Authors: Krishna P Datla; Virginia Zbarsky; Deepal Rai; Shabnam Parkar; Naomi Osakabe; Okezie I Aruoma; David T Dexter Journal: J Am Coll Nutr Date: 2007-08 Impact factor: 3.169
Authors: Tiina M Kääriäinen; Marjo Piltonen; Bernardino Ossola; Heli Kekki; Sárka Lehtonen; Terhi Nenonen; Anne Lecklin; Atso Raasmaja; Pekka T Männistö Journal: Brain Res Date: 2008-02-13 Impact factor: 3.252
Authors: Xiang Gao; Honglei Chen; Hyon K Choi; Gary Curhan; Michael A Schwarzschild; Alberto Ascherio Journal: Am J Epidemiol Date: 2008-03-07 Impact factor: 4.897
Authors: Hagen Schroeter; Parmvir Bahia; Jeremy P E Spencer; Olivia Sheppard; Marcus Rattray; Enrique Cadenas; Catherine Rice-Evans; Robert J Williams Journal: J Neurochem Date: 2007-02-07 Impact factor: 5.372
Authors: Katherine E Strathearn; Gad G Yousef; Mary H Grace; Susan L Roy; Mitali A Tambe; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Mary Ann Lila; Jean-Christophe Rochet Journal: Brain Res Date: 2014-02-03 Impact factor: 3.252
Authors: Aurélie de Rus Jacquet; Michael Timmers; Sin Ying Ma; Andrew Thieme; George P McCabe; Jay Hansford C Vest; Mary Ann Lila; Jean-Christophe Rochet Journal: J Ethnopharmacol Date: 2017-02-15 Impact factor: 4.360
Authors: Amy M Griggs; Zeynep S Agim; Vartika R Mishra; Mitali A Tambe; Alison E Director-Myska; Kenneth W Turteltaub; George P McCabe; Jean-Christophe Rochet; Jason R Cannon Journal: Toxicol Sci Date: 2014-04-09 Impact factor: 4.849
Authors: Katherine C Hughes; Xiang Gao; Iris Y Kim; Eric B Rimm; Molin Wang; Marc G Weisskopf; Michael A Schwarzschild; Alberto Ascherio Journal: Mov Disord Date: 2016-10-27 Impact factor: 10.338
Authors: Krista McFarland; Diana L Price; Christopher N Davis; Jian-Nong Ma; Douglas W Bonhaus; Ethan S Burstein; Roger Olsson Journal: ACS Chem Neurosci Date: 2013-08-06 Impact factor: 4.418